EBITDA CAGR uses clean operating EBITDA derived from reported operating income plus depreciation and amortization.
Over longer horizons, EBITDA CAGR averages -32.09% over 3 years and -18.71% over 5 years; the trailing 12 months came in at -56.78%. EBITDA CAGR shows how the company's operating profitability has grown before depreciation and amortization. This reflects the growth of the core business's cash-operating earnings power, independent of capital-intensity and accounting depreciation choices.
Diversified Healthcare Trust (DHC)
EBITDA growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Reported quarterly EBITDA; no daily interpolation. Q2 FY2026 (2026-06-30): $62.02M.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A Quote observation: 2026-10-06T20:31:09.094Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| Year | Start EBITDA | End EBITDA | Change | % Change |
|---|---|---|---|---|
| 2025 | $514.92M | $222.66M | −$292.26M | -56.76% |
| 2024 | $483.01M | $514.92M | +$31.91M | +6.61% |
| 2023 | $148.31M | $483.01M | +$334.71M | +225.69% |
| 2022 | $257.31M | $148.31M | −$109.01M | -42.36% |
| 2021 | $627.00M | $257.31M | −$369.69M | -58.96% |
| 2020 | $783.19M | $627.00M | −$156.19M | -19.94% |
| 2019 | $859.95M | $783.19M | −$76.76M | -8.93% |
| 2018 | $828.65M | $859.95M | +$31.30M | +3.78% |
| 2017 | $892.48M | $828.65M | −$63.83M | -7.15% |
| 2016 | $567.26M | $892.48M | +$325.22M | +57.33% |
| 2015 | $474.46M | $567.26M | +$92.80M | +19.56% |
| 2014 | $421.19M | $474.46M | +$53.27M | +12.65% |
| 2013 | $397.79M | $421.19M | +$23.40M | +5.88% |
| 2012 | $340.78M | $397.79M | +$57.01M | +16.73% |
| 2011 | $295.23M | $340.78M | +$45.55M | +15.43% |
| 2010 | $188.91M | $295.23M | +$106.32M | +56.28% |
| 2009 | $169.25M | $188.91M | +$19.65M | +11.61% |
| 2008 | $170.84M | $169.25M | −$1.59M | -0.93% |
| 2007 | $157.22M | $170.84M | +$13.63M | +8.67% |
| 2006 | $145.31M | $157.22M | +$11.90M | +8.19% |
| 2005 | $138.77M | $145.31M | +$6.55M | +4.72% |
| 2004 | $120.66M | $138.77M | +$18.11M | +15.01% |
| 2003 | $113.82M | $120.66M | +$6.84M | +6.01% |
| 2002 | $43.78M | $113.82M | +$70.04M | +159.96% |
| 2001 | $66.53M | $43.78M | −$22.75M | -34.19% |
| 2000 | $55.85M | $66.53M | +$10.68M | +19.12% |
| 1999 | $83.83M | $55.85M | −$27.98M | -33.38% |
| Period | Period End | Value | QoQ Growth | YoY Growth |
|---|---|---|---|---|
| Q2 FY2026 | 2026-06-30 | $62.02M | +6.6% | +5.2% |
| Q1 FY2026 | 2026-03-31 | $58.18M | +14.3% | -55.9% |
| Q4 FY2025 | 2025-12-31 | $50.89M | +0.7% | -63.8% |
| Q3 FY2025 | 2025-09-30 | $50.56M | -14.3% | -57.4% |
| Q2 FY2025 | 2025-06-30 | $58.98M | -55.3% | -53.8% |
| Q1 FY2025 | 2025-03-31 | $131.87M | -6.1% | +4.9% |
| Q4 FY2024 | 2024-12-31 | $140.46M | +18.4% | +4.2% |
| Q3 FY2024 | 2024-09-30 | $118.67M | -7.0% | +3.4% |
| Q2 FY2024 | 2024-06-30 | $127.63M | +1.5% | +10.9% |
| Q1 FY2024 | 2024-03-31 | $125.68M | -6.7% | +6.1% |
| Q4 FY2023 | 2023-12-31 | $134.74M | +17.4% | +24.1% |
| Q3 FY2023 | 2023-09-30 | $114.72M | -0.3% | +30.7% |
| Q2 FY2023 | 2023-06-30 | $115.08M | -2.9% | +18.1% |
| Q1 FY2023 | 2023-03-31 | $118.47M | +9.1% | +30.0% |
| Q4 FY2022 | 2022-12-31 | $108.57M | +23.6% | -8.7% |
| Q3 FY2022 | 2022-09-30 | $87.81M | -9.9% | -30.4% |
QoQ Growth compares the previous fiscal quarter; YoY Growth compares the same fiscal quarter in the prior fiscal year. Missing or ambiguous fiscal periods render N/A.
